Physician profile
Robert Haake
NPI 1659869147
$1,920.55
in general payments reported to CMS, 2019-2025
18 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2022: $63.32 · 2024: $483 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,711.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $399.23 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $182.58 | 2025 | Intracept |
| Collegium Pharmaceutical, INC. | $169.94 | 2025 | Xtampza, Belbuca |
| Pfizer INC. | $168.65 | 2019-2025 | |
| Globus Medical, INC. | $144.54 | 2025 | Senza |
| Abbott Laboratories | $140.59 | 2025 | Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.17 | 2025 | Relistor |
| Scilex Pharmaceuticals INC. | $132.19 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Libtayo |
| Abbvie INC. | $82.22 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $60.14 | 2025 | |
| Impel Pharmaceuticals LLC | $34.01 | 2025 | Trudhesa |
| Tela Bio, INC. | $32.10 | 2019 | |
| Axsome Therapeutics, INC. | $28.76 | 2025 | Symbravo |
| Merz Pharmaceuticals, LLC | $24.28 | 2025 | Xeomin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $22.24 | 2022 | |
| Tonix Medicines, INC. | $18.73 | 2025 | Tonmya |
| Protega Pharmaceutials INC | $16.18 | 2025 | Roxybond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Haake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.